# EDRF1

## Overview
EDRF1, or erythroid differentiation regulatory factor 1, is a gene that encodes a transcription factor pivotal in the regulation of erythropoiesis, the process by which red blood cells are formed. The protein product of EDRF1 functions primarily as a transcriptional activator within the nucleus, where it influences the expression of genes critical for erythroid differentiation, such as the globin gene, which is vital for hemoglobin synthesis (Ponomarenko2020Unannotated; Chen2021Discovering). Beyond its role in erythropoiesis, EDRF1 is implicated in the chaperome network, particularly in cancer cells, where it acts as a co-chaperone, facilitating interactions between HSP90 and HSP70 chaperone machineries to manage proteotoxic stress (Joshi2018Adapting). The gene's involvement in alternative splicing under certain physiological conditions suggests a multifaceted role that may extend to other biological processes (Rey2021Analysis).

## Function
EDRF1 (erythroid differentiation regulatory factor 1) is a transcription factor involved in the regulation of erythropoiesis, the process of red blood cell formation. It plays a crucial role in the differentiation of erythroid progenitor cells into mature red blood cells by influencing gene expression related to erythroid differentiation. EDRF1 is active in the nucleus, where it functions as a transcriptional activator, particularly affecting the globin gene, which is essential for hemoglobin production (Ponomarenko2020Unannotated; Chen2021Discovering).

In addition to its role in erythropoiesis, EDRF1 is involved in the chaperome network, particularly in cancer cells. It acts as a co-chaperone, facilitating interactions between the HSP90 and HSP70 chaperone machineries. This interaction is crucial for managing proteotoxic stress in cancer cells, suggesting that EDRF1 may have a broader role in cellular stress responses beyond erythroid differentiation (Joshi2018Adapting).

The gene's involvement in alternative splicing under certain physiological conditions in mammals indicates a potential complexity in its function, which might extend to other biological processes beyond erythropoiesis (Rey2021Analysis).


## References


[1. (Rey2021Analysis) Sonia Rey, Xingkun Jin, Børge Damsgård, Marie-Laure Bégout, and Simon Mackenzie. Analysis across diverse fish species highlights no conserved transcriptome signature for proactive behaviour. BMC Genomics, January 2021. URL: http://dx.doi.org/10.1186/s12864-020-07317-z, doi:10.1186/s12864-020-07317-z. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12864-020-07317-z)

[2. (Ponomarenko2020Unannotated) Mikhail Ponomarenko, Ekaterina Sharypova, Irina Drachkova, Irina Chadaeva, Olga Arkova, Olga Podkolodnaya, Petr Ponomarenko, Nikolay Kolchanov, and Ludmila Savinkova. Unannotated single nucleotide polymorphisms in the tata box of erythropoiesis genes show in vitro positive involvements in cognitive and mental disorders. BMC Medical Genetics, October 2020. URL: http://dx.doi.org/10.1186/s12881-020-01106-x, doi:10.1186/s12881-020-01106-x. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12881-020-01106-x)

[3. (Chen2021Discovering) Zheling Chen and Minyao Ge. Discovering pathways in benign prostate hyperplasia: a functional genomics pilot study. Experimental and Therapeutic Medicine, January 2021. URL: http://dx.doi.org/10.3892/etm.2021.9673, doi:10.3892/etm.2021.9673. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/etm.2021.9673)

[4. (Joshi2018Adapting) Suhasini Joshi, Tai Wang, Thaís L. S. Araujo, Sahil Sharma, Jeffrey L. Brodsky, and Gabriela Chiosis. Adapting to stress — chaperome networks in cancer. Nature Reviews Cancer, 18(9):562–575, May 2018. URL: http://dx.doi.org/10.1038/s41568-018-0020-9, doi:10.1038/s41568-018-0020-9. This article has 108 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41568-018-0020-9)